Step 3: Conduct comprehensive literature searches on your research question to find all the evidence. This is where the librarian is most involved:
PRISMA-S Literature Search Extension is a standard for clear and concise reporting of your search methodology. It is a 16-item checklist that covers multiple aspects of the search process for systematic reviews. It is intended to guide reporting, not conduct, of the search. The checklist should be read in conjunction with the Explanation and Elaboration (Part 3), which provides more detail about each item.
Rethlefsen ML, Kirtley S, Waffenschmidt S, Ayala AP, Moher D, Page MJ, Koffel JB; PRISMA-S Group. PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews. Syst Rev. 2021 Jan 26;10(1):39. doi: 10.1186/s13643-020-01542-z. PMID: 33499930; PMCID: PMC7839230.
Lefebvre C, Glanville J, Briscoe S, Littlewood A, Marshall C, Metzendorf M-I, Noel-Storr A, Rader T, Shokraneh F, Thomas J, Wieland LS. Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021).
Institute of Medicine 2011. Finding What Works in Health Care: Standards for Systematic Reviews. Washington, DC: The National Academies Press. https://doi.org/10.17226/13059.
In step 3, partner with a librarian early on in the process:
The goal of a systematic retrieve is to find all results that are relevant to your topic. Because systematic review searches are quite extensive and retrieve large numbers of results, an important aspect of systematic searching is creating a high quality search and limiting the number of irrelevant results that need to be screened. In addition to having a high quality search, the searches should be well-documented and reproducible. Click through the tabs below to review core tenets and guidance from both the Cochrane Handbook for Systematic Reviews, the National Academies Press / IOM and the PRISMA-S Extension.
Librarians are experts trained in literature searching and systematic review methodology. Partner with the Systematic Review Librarians at UAB to save time and improve the quality of your review. Our Librarian Expertise page details how our librarians collaborate with and contribute to systematic review teams.
Based on the Bramer Search Method, librarians are advised to use a combination of at least three databases for optimal retrieval of studies. Regardless of the systematic review's topic, "a combination of Embase, Ovid MEDLINE, Web of Science Core Collection, & Google Scholar (only the first 200 relevant citations) performed best, achieving an overall recall of 98.3 and 100% recall in 72% of systematic reviews" (Bramer, 2017).
The Core Major Biomedical Databases from UAB Libraries that should be considered for inclusion in health-related Systematic Review searches:
To learn how to conduct searches in health sciences databases, watch this short tutorial:
Many systematic review topics benefit from using subject-specific databases that offer robust coverage and unique citations within their respective fields. These specialized resources ensure a more comprehensive and relevant evidence base for your review:
Business Source Premier indexes key business journals and is valuable for reviews in business and marketing research.
CINAHL Plus provides strong coverage of nursing and allied health literature.
ClinicalTrials is a registry of federal and private clinical trials to support intervention reviews.
ERIC (ProQuest) or ERIC (EBSCO) is an education research database.
Physiotherapy Evidence Database (PEDro) includes unique clinical trials and research related to sports medicine and physiotherapy.
PsycINFO is essential for literature in psychology and mental health.
Sociological Abstracts and Social Sciences Full Text support research in sociology and the behavioral sciences.
SPORTDiscus contains literature in exercise physiology, sports medicine, and fitness.
To explore our full range of databases, visit our Databases page. A librarian is also available to help you identify the most appropriate databases for your research topic or discipline.
"Grey literature stands for manifold document types produced on all levels of government, academics, business and industry in print and electronic formats that are protected by intellectual property rights, of sufficient quality to be collected and preserved by libraries and institutional repositories, but not controlled by commercial publishers; i.e. where publishing is not the primary activity of the producing body."
- The Twelfth International Conference on Grey Literature in Prague in 2010.
Examples of grey literature include: conference abstracts, presentations, proceedings; regulatory data; unpublished trial data; government publications; reports (such as white papers, working papers, internal documentation); dissertations/theses; patents; and policies & procedures.
Inclusion of grey literature into a systematic review is recommended in order to help minimize publication bias. The inclusion of grey literature in systematic reviews is widely recognized as important and international organizations have incorporated this information in their guidelines and manuals for working on reviews and meta-analyses.
Searching the grey literature can be a daunting task. You should search those resources that make the most sense for your research question. At a minimum, consider searching unpublished trial data through trial registries as well as conference abstracts. Also check out the papers and reports of relevant stakeholder organizations.
The links below may shed some additional light on the process.
Online clinical trial registries can be valuable sources for identifying completed but unpublished clinical trials. These resources often provide otherwise inaccessible information, including additional details about published studies. While some registries include study results, even the identification of a trial—regardless of result availability—can be useful, as reviewers may contact the principal investigator directly for further information. Many pharmaceutical companies also host trial registries on their own websites, though the quality and completeness of these vary.
These organizations and repositories offer access to international research outputs, systematic reviews, and grey literature. They can be valuable for identifying health interventions, public health studies, and region-specific evidence not indexed in traditional databases.
Centre for Reviews and Dissemination (UK): Based at the University of York, CRD conducts and supports systematic reviews and maintains key databases including DARE, NHS EED, and HTA, which provide high-quality evidence on health and social care interventions.
INAHTA (International Network of Agencies for Health Technology Assessment): A non-profit network of 50+ member agencies from around the world. Focuses on sharing evidence-based assessments to inform health policy and decision-making.
INIST (Institut de l’Information Scientifique et Technique): Part of the French National Center for Scientific Research (CNRS), INIST develops tools and services to enhance access to international scientific and technical information, especially from basic and applied research.
WHO International Clinical Trials Registry Platform (ICTRP): Aggregates clinical trial data from registries worldwide to ensure transparency and accessibility of global clinical research.
Lenus (Irish Health Repository): Managed by the Health Service Executive (HSE) Library, Lenus provides open access to Irish health research, including theses, reports, and evaluations.
NARCIS (Netherlands): Formerly the national portal for Dutch research information, NARCIS provided access to publications, datasets, and researcher profiles (note: now integrated into the Dutch Research Portal via NWO/DTL).
RIAN (Ireland): The national open access research portal for Ireland. Aggregates research from Irish institutional repositories, including dissertations, articles, and technical reports.
UK Clinical Research Network (UKCRN) Study Portfolio: A searchable portfolio of studies supported by the NIHR Clinical Research Network. Includes studies from England, Wales, Scotland, and Northern Ireland.
Virtual Health Library (VHL/BVS): Coordinated by the Pan American Health Organization, the VHL provides access to Latin American and Caribbean health science literature and grey literature across multiple regional databases (e.g., LILACS).
WHO Publications: The World Health Organization’s official platform for reports, guidelines, technical documents, and global health research outputs.
Many pharmaceutical companies maintain registries or databases of their sponsored clinical trials. While the level of transparency and data availability varies, these sites can provide results for completed studies that may not be published in peer-reviewed journals. They are valuable for identifying unpublished or supplemental trial data relevant to systematic reviews.
AstraZeneca Clinical Trials: Provides information on AstraZeneca-sponsored clinical trials, including summaries of results and links to external trial listings.
Bristol-Myers Squibb Clinical Trial Registry: Offers access to BMS-sponsored clinical trial protocols, study results, and related publications.
Eli Lilly Clinical Trial Registry: Shares summaries and results of Eli Lilly–sponsored trials. May link to results published elsewhere, but generally limited to study-level reporting.
GSK Clinical Study Register: A comprehensive register of clinical trials sponsored by GlaxoSmithKline. Includes protocols, summaries, results, and links to journal publications when available.
Novartis Clinical Trials: Offers access to Novartis-sponsored study protocols and results, including postings on ClinicalTrials.gov and EudraCT.
Pfizer Oncology Clinical Trials: Focused on oncology trials; transparency of detailed study results may vary. Also see Pfizer’s broader data sharing platform: Pfizer Clinical Trials.
Roche Clinical Trial Protocol Registry: Provides access to study protocols and result summaries from Roche-sponsored clinical trials.
Note: Transparency and usability of pharmaceutical company trial registries can vary. Researchers are encouraged to verify data availability and consult ClinicalTrials.gov or the EU Clinical Trials Register for broader context or supplementary information.
The drug and device approval process often requires submission of detailed clinical data that may not be available through traditional publication channels. These regulatory sources can help reviewers identify potential publication bias and gather supplementary trial data. While some documents may be redacted or only available post-approval, they offer valuable insight into both published and unpublished research.
Primary Sources:
Drugs@FDA: Hosted by the U.S. Food and Drug Administration, this database can be searched by drug name or active ingredient. Within each drug’s page, select “Approval History, Letters, Reviews, and Related Documents” to access internal FDA reviews, which often summarize clinical trial data submitted during the approval process.
Devices@FDA: Includes approval documents and summaries for medical devices cleared by the FDA from 1995 onward. Documents often include clinical trial results, safety summaries, and effectiveness data.
Health Canada Drug Product Database (DPD): A comprehensive source for drugs approved in Canada. Some entries include links to drug monographs, which may summarize trial data or reference supporting clinical studies.
European Public Assessment Reports (EPARs): Published by the European Medicines Agency (EMA), EPARs provide detailed scientific assessments for all centrally authorized medicines in the EU. These reports typically include summaries of pre-approval clinical trial data.
Additional Resources:
FDA Dockets Management: The FDA’s public docket system for administrative proceedings and rulemaking. It includes documents such as hearing transcripts, public comments, and presentation materials. Occasionally, these contain unpublished trial data discussed in regulatory settings.
FDA MedWatch: The FDA’s safety reporting system, providing safety alerts, labeling changes, and voluntary reporting tools for adverse events related to medical products.
Drug Information Portal: Managed by the National Library of Medicine, this portal aggregates information on drugs from multiple sources, including the FDA, CDC, and NIH. Useful for quickly locating regulatory and research context for a specific drug.
These tools and repositories can help identify non-commercial, non-peer-reviewed, or hard-to-find literature such as reports, theses, preprints, protocols, and institutional research. They are essential for reducing publication bias and ensuring comprehensive systematic reviews.
Google Scholar: A freely accessible web search engine that indexes scholarly literature across disciplines. It includes journal articles, theses, books, abstracts, and court opinions. Note: Coverage is broad but not transparent, and search algorithms are proprietary.
Grey Literature Report (Archived): Formerly maintained by the New York Academy of Medicine, this quarterly publication indexed public health grey literature. Though no longer updated after 2016, past reports remain useful for historical context.
Joanna Briggs Institute (JBI): An international organization based at the University of Adelaide that produces systematic reviews and other forms of evidence syntheses focused on feasibility, appropriateness, and clinical effectiveness in healthcare. JBI reviews are often included in Ovid and JBI’s own EBP Database.
OAIster: A union catalog of millions of records from open access repositories, managed by OCLC. Useful for locating grey literature, dissertations, and institutional reports.
OpenDOAR (Directory of Open Access Repositories): A global directory of academic open access repositories, searchable by country, institution, or subject. Helps identify sources for unpublished or institutionally archived research outputs.
PROSPERO (International Prospective Register of Systematic Reviews): A global registry for systematic reviews in health and social care. Records review protocols at inception, helping promote transparency and reduce duplication. Also enables comparison between planned and reported methods/results.
Registry of Open Access Repositories (ROAR): An international registry that indexes open access repositories to support the growth of open scholarly communication.
Sigma Repository (formerly Virginia Henderson Global Nursing e-Repository): An open-access platform hosted by Sigma Theta Tau International, dedicated to sharing nursing-focused research, education materials, and evidence-based practice projects. Especially useful for identifying grey literature in nursing.
This page was based on pages from the University of North Carolina Health Sciences Library and Duke University Medical Center Library & Archives guides on screening in systematic reviews. We are grateful for their support and assistance.
The design of this page was adapted in part from Research: By Course, Subject, or Topic, by University of Arizona Libraries, © 2020 The Arizona Board of Regents on behalf of The University of Arizona, licensed under a Creative Commons Attribution 4.0 International License.